FKTN
Basic information
Region (hg38): 9:105558122-105653820
Previous symbols: [ "FCMD" ]
Links
Phenotypes
GenCC
Source:
- autosomal recessive limb-girdle muscular dystrophy type 2M (Definitive), mode of inheritance: AR
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 (Strong), mode of inheritance: AR
- dilated cardiomyopathy 1X (Limited), mode of inheritance: AR
- familial isolated dilated cardiomyopathy (Supportive), mode of inheritance: AD
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 (Supportive), mode of inheritance: AR
- muscular dystrophy-dystroglycanopathy, type A (Supportive), mode of inheritance: AR
- muscle-eye-brain disease (Supportive), mode of inheritance: AR
- autosomal recessive limb-girdle muscular dystrophy type 2M (Supportive), mode of inheritance: AR
- congenital muscular dystrophy without intellectual disability (Supportive), mode of inheritance: AR
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 (Definitive), mode of inheritance: AR
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 (Strong), mode of inheritance: AR
- autosomal recessive limb-girdle muscular dystrophy type 2M (Strong), mode of inheritance: AR
- myopathy caused by variation in FKTN (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cardiomyopathy, dilated, 1X; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4; Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4 | AR | Cardiovascular; Musculoskeletal | Surveillance for cardiovascular complications may allow early diagnosis and treatment, which may ameliorate morbidity and mortality; Cardiomyopathy, dilated, 1X has been reported as being treated with transplant; Individuals with Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4 has been reported as benefiting from treatment with steroids | Cardiovascular; Musculoskeletal; Neurologic; Ophthalmologic | 7258547; 8124873; 9690476; 10545611; 10817652; 12601708; 17036286; 17044012; 17878207; 18177472; 19015585; 19342235; 19299310; 19179078; 19842201; 20627570; 20961758 |
ClinVar
This is a list of variants' phenotypes submitted to
- Walker-Warburg_congenital_muscular_dystrophy (723 variants)
- Cardiovascular_phenotype (265 variants)
- not_provided (223 variants)
- Dilated_cardiomyopathy_1X (145 variants)
- Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),_type_A,_4 (144 variants)
- Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2M (99 variants)
- Muscular_dystrophy-dystroglycanopathy_(congenital_without_intellectual_disability),_type_B4 (96 variants)
- not_specified (76 variants)
- Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),_type_A1 (40 variants)
- FKTN-related_disorder (21 variants)
- Cardiomyopathy (4 variants)
- See_cases (3 variants)
- Myopathy_caused_by_variation_in_FKTN (3 variants)
- Hypertrophic_cardiomyopathy (2 variants)
- Dilated_Cardiomyopathy,_Recessive (2 variants)
- Global_developmental_delay (1 variants)
- Ventricular_tachycardia (1 variants)
- Primary_dilated_cardiomyopathy (1 variants)
- Primary_familial_dilated_cardiomyopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FKTN gene is commonly pathogenic or not. These statistics are base on transcript: NM_001079802.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 201 | 209 | ||||
missense | 24 | 349 | 13 | 389 | ||
nonsense | 23 | 25 | 48 | |||
start loss | 1 | 1 | 2 | |||
frameshift | 29 | 48 | 84 | |||
splice donor/acceptor (+/-2bp) | 27 | 33 | ||||
Total | 55 | 127 | 366 | 215 | 2 |
Highest pathogenic variant AF is 0.000183708
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FKTN | protein_coding | protein_coding | ENST00000223528 | 9 | 82989 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.66e-7 | 0.982 | 125569 | 0 | 179 | 125748 | 0.000712 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0466 | 239 | 237 | 1.01 | 0.0000123 | 3051 |
Missense in Polyphen | 60 | 62.521 | 0.95968 | 808 | ||
Synonymous | 1.24 | 72 | 86.7 | 0.830 | 0.00000461 | 836 |
Loss of Function | 2.18 | 14 | 26.0 | 0.538 | 0.00000141 | 299 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00158 | 0.00158 |
Ashkenazi Jewish | 0.00785 | 0.00787 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000229 | 0.000229 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000425 | 0.000425 |
Other | 0.000656 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Glycosyltransferase involved in the biosynthesis of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine- beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1). Required for normal location of POMGNT1 in Golgi membranes, and for normal POMGNT1 activity (PubMed:17034757). May interact with and reinforce a large complex encompassing the outside and inside of muscle membranes. Could be involved in brain development. {ECO:0000269|PubMed:17034757, ECO:0000269|PubMed:25279699}.;
- Disease
- DISEASE: Muscular dystrophy-dystroglycanopathy congenital without mental retardation B4 (MDDGB4) [MIM:613152]: An autosomal recessive disorder characterized by congenital muscular dystrophy and evidence of dystroglycanopathy. Features included increased serum creatine kinase, generalized weakness, mild white matter changes on brain MRI, and absence of mental retardation. {ECO:0000269|PubMed:14627679, ECO:0000269|PubMed:18177472, ECO:0000269|PubMed:19179078, ECO:0000269|PubMed:19299310}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Muscular dystrophy-dystroglycanopathy limb-girdle C4 (MDDGC4) [MIM:611588]: An autosomal recessive degenerative myopathy characterized by progressive weakness of the pelvic and shoulder girdle muscles, and elevated serum creatine kinase. MDDGC4 has no brain involvement and a remarkable clinical response to corticosteroids. {ECO:0000269|PubMed:17044012, ECO:0000269|PubMed:19342235}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1X (CMD1X) [MIM:611615]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:17036286}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Mannose type O-glycan biosynthesis - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.389
Intolerance Scores
- loftool
- 0.322
- rvis_EVS
- 0.58
- rvis_percentile_EVS
- 82.25
Haploinsufficiency Scores
- pHI
- 0.0950
- hipred
- N
- hipred_score
- 0.348
- ghis
- 0.521
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.479
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fktn
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; growth/size/body region phenotype; muscle phenotype;
Zebrafish Information Network
- Gene name
- fktn
- Affected structure
- ocular blood vessel
- Phenotype tag
- abnormal
- Phenotype quality
- deformed
Gene ontology
- Biological process
- protein O-linked glycosylation;nervous system development;muscle organ development;negative regulation of cell population proliferation;protein O-linked mannosylation;negative regulation of JNK cascade;regulation of protein glycosylation
- Cellular component
- extracellular space;nucleus;endoplasmic reticulum;Golgi apparatus;cis-Golgi network;integral component of Golgi membrane
- Molecular function
- protein binding;transferase activity